Brand Name | Status | Last Update |
---|---|---|
ctx3 rinse | OTC monograph final | 2022-12-31 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Breast neoplasms | D001943 | EFO_0003869 | C50 | 1 | 7 | 5 | — | — | 12 |
Multiple myeloma | D009101 | — | C90.0 | 1 | 2 | 1 | — | — | 4 |
Plasma cell neoplasms | D054219 | — | — | 1 | 2 | 1 | — | — | 4 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Lymphoma | D008223 | — | C85.9 | 3 | 4 | — | — | — | 5 |
Adenocarcinoma | D000230 | — | — | 1 | 3 | — | — | — | 4 |
Carcinoma | D002277 | — | C80.0 | 3 | 1 | — | — | — | 4 |
Neoplasms | D009369 | — | C80 | 3 | 2 | — | — | — | 3 |
Melanoma | D008545 | — | — | 1 | 1 | — | — | 1 | 3 |
Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | — | 3 | — | — | — | 3 |
Leukemia | D007938 | — | C95 | 2 | 1 | — | — | — | 3 |
Non-hodgkin lymphoma | D008228 | — | C85.9 | 2 | 2 | — | — | — | 3 |
Large b-cell lymphoma diffuse | D016403 | — | C83.3 | 2 | 2 | — | — | — | 3 |
Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 1 | 2 | — | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Lymphoid leukemia | D007945 | — | C91 | 2 | — | — | — | — | 2 |
Squamous cell carcinoma | D002294 | — | — | 2 | — | — | — | — | 2 |
Skin neoplasms | D012878 | EFO_0004198 | C44 | 1 | — | — | — | — | 1 |
B-cell chronic lymphocytic leukemia | D015451 | — | C91.1 | 1 | — | — | — | — | 1 |
Follicular lymphoma | D008224 | — | C82 | 1 | — | — | — | — | 1 |
Interdigitating dendritic cell sarcoma | D054739 | — | C96.4 | 1 | — | — | — | — | 1 |
Squamous cell neoplasms | D018307 | — | — | 1 | — | — | — | — | 1 |
Adenosquamous carcinoma | D018196 | — | — | 1 | — | — | — | — | 1 |
Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | 1 | — | — | — | — | 1 |
Philadelphia chromosome | D010677 | — | — | 1 | — | — | — | — | 1 |
Drug common name | Lornoxicam |
INN | lornoxicam |
Description | Lornoxicam, also known as chlortenoxicam, is a nonsteroidal anti-inflammatory drug (NSAID) of the oxicam class with analgesic (pain relieving), anti-inflammatory and antipyretic (fever reducing) properties. It is available in oral and parenteral formulations.
|
Classification | Small molecule |
Drug class | anti-inflammatory agents (isoxicam type) |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | CN1C(C(=O)Nc2ccccn2)=C(O)c2sc(Cl)cc2S1(=O)=O |
PDB | — |
CAS-ID | 70374-39-9 |
RxCUI | — |
ChEMBL ID | CHEMBL1569487 |
ChEBI ID | 31783 |
PubChem CID | 5282204 |
DrugBank | DB06725 |
UNII ID | ER09126G7A (ChemIDplus, GSRS) |